VisMederi s.r.l., Siena, Italy.
VisMederi Research s.r.l., Siena, Italy.
J Virol Methods. 2021 Nov;297:114261. doi: 10.1016/j.jviromet.2021.114261. Epub 2021 Aug 14.
The neutralization assays are considered the gold-standard being capable of evaluating and detecting, functional antibodies. To date, many different protocols exist for micro-neutralization (MN) assay which varies in several steps: cell number and seeding conditions, virus amount used in the infection step, virus-serum-cells incubation time and read out. The aim of the present preliminary study was to carry out SARS-CoV-2 wild type MN assay in order to investigate which optimal tissue culture infective dose 50 (TCID) infective dose in use is the most adequate choice for implementation in terms of reproducibility, standardization possibilities and comparability of results. Therefore, we assessed the MN by using two viral infective doses: the "standard" dose of 100 TCID/well and a reduced dose of 25 TCID/well. The results obtained, yielded by MN on using the lower infective dose (25 TCID50), were higher respect to those obtained with the standard infective dose. This suggests that the lower dose can potentially have a positive impact on the detection and estimation of real amount of neutralizing antibodies present in a given sample, showing higher sensitivity maintaining high specificity.
中和测定法被认为是评估和检测功能性抗体的金标准。迄今为止,已经存在许多不同的用于微量中和(MN)测定的方案,这些方案在多个步骤中有所不同:细胞数量和播种条件、感染步骤中使用的病毒量、病毒-血清-细胞孵育时间和读取。本初步研究的目的是进行 SARS-CoV-2 野生型 MN 测定,以研究在重复性、标准化可能性和结果可比性方面,哪种最适当的组织培养感染剂量 50(TCID)感染剂量是最佳选择。因此,我们使用两种病毒感染剂量来评估 MN:“标准”剂量为 100 TCID/孔和降低的剂量为 25 TCID/孔。使用较低感染剂量(25 TCID50)进行 MN 获得的结果高于使用标准感染剂量获得的结果。这表明较低的剂量可能对检测和估计给定样本中存在的实际中和抗体数量产生积极影响,显示出更高的敏感性,同时保持高特异性。